CCCC
C4 Therapeutics Inc
3.00$
-6.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +37.4% | +53.0% | -17.0% | +41.9% | -12.6% | -2.2% | -10.1% | +31.7% | -13.1% | +136.2% | -61.9% | +80.7% | -51.2% | -57.7% | +31.7% | -29.1% | +315.6% | -70.5% | -6.8% | +295.1% | +28.0% | -66.3% | +39.8% | -10.7% | +73.8% | -1.9% | -44.2% | +7.9% | – | |
| – | +0.0% | +35.6% | +23.7% | +1.8% | +8.9% | +34.8% | -14.6% | +0.5% | +13.4% | +4.4% | +9.3% | -1.3% | +19.5% | -5.3% | +3.3% | -5.3% | -93.2% | +0.3% | -15.2% | +19.9% | +0.9% | +0.5% | -14.1% | +14.0% | +3.5% | – | – | -0.3% | – | – | |
| – | – | – | – | – | – | -12.6% | -244.1% | – | – | – | – | – | – | – | – | – | – | +240.7% | -82.7% | +93.6% | +227.8% | +33.6% | -74.4% | +112.2% | -10.7% | +73.8% | -1.9% | -60.5% | +52.6% | – | |
| – | +31.2% | +0.0% | +27.9% | +1.8% | +8.9% | +34.8% | -14.6% | +0.5% | +13.4% | +4.4% | +9.3% | -1.3% | +19.5% | -5.3% | +3.3% | -5.3% | +3.0% | -5.3% | +7.2% | -25.9% | +5.4% | +34.0% | +2.1% | -16.7% | -3.2% | -0.8% | -3.9% | -1.5% | -0.5% | – | |
| – | +0.0% | +31.8% | +11.3% | +5.6% | -2.6% | +3.3% | +135.3% | +10.1% | +16.2% | -1.8% | +3.9% | +46.0% | -22.8% | -3.2% | +9.6% | +4.3% | -5.8% | +2.2% | -2.2% | -0.1% | -5.8% | +21.4% | -11.9% | -10.1% | -6.0% | +1.7% | +2.9% | +1.7% | -7.9% | – | |
| – | +768.8% | +0.0% | -81.6% | +5.6% | +622.3% | +30.5% | -74.9% | +315.0% | -69.2% | -1.8% | +3.9% | +46.0% | -22.8% | -3.2% | +9.6% | +4.3% | +267.6% | -8.3% | +5.7% | -9.6% | -10.9% | +32.3% | -1.0% | -11.5% | -4.0% | +30.5% | -25.2% | -5.9% | +2.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -51.0% | +342.5% | +47.7% | -35.7% | -0.2% | +1.1% | +0.0% | -2.2% | +1.3% | +3.7% | +8.5% | +0.8% | -1.0% | -72.2% | +1,344.3% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +420.0% | -85.2% | +74.0% | -200.6% | – | – | -41.9% | -4.2% | +59.4% | +390.0% | -53.4% | -88.8% | -1,992.9% | – | – | – | -43.9% | -72.4% | -831.8% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.